Innovating for health security (WHA79)

21 May 2026 GENEVA
Date

21 May 2026

Time

18:00 - 21:00 CET

Location

Restaurant Vieux Bois
12, Avenue de la Paix
1202 Geneva

Attendance

This event is being held both in person and online.

Registration info
The global health landscape is facing converging pressures: resurgent infectious diseases, climate-driven outbreaks, rising AMR, zoonotic spillover, and increasingly interconnected populations.  

As highlighted in the recent IFPMA supported health security analysis, protecting societies from these threats requires sustained investment in systems that prevent, detect, and respond to health challenges—not only during crises but continuously.  

Innovation plays a central role across this continuum. From cutting-edge epidemiological tools and genomic surveillance to next generation vaccines, therapeutics, diagnostics, and delivery systems, new advances are redefining what is possible for preparedness and response. Yet innovation only delivers impact when systems, regulatory pathways, and collaboration mechanisms and trust allow new solutions to reach people quickly and equitably. This event brings together thought leaders to explore how health innovation can strengthen global resilience, drawing on real-world lessons and forward-looking opportunities.  

Address

Restaurant Vieux Bois,
Avenue de la Paix 12,
1202 Genève, Switzerland

Register to attend

You can attend this event either in person or online. To book your place select your preference using the buttons below and continue through to the registration page.

Join in person Join online

Speakers

Shiulie Ghosh Moderator
Dr Joy Phumaphi Co-Chair, the Global Preparedness Monitoring Board (GPMB); former Minister of Health, Botswana

Joy Phumaphi is a former Minister of Health of Botswana; former Assistant Director General at WHO; and Former Vice President & Head of Human Development Network at the World Bank. She chairs the Botswana National Gender Commission and is Board Chair of the Rollback Malaria Partnership to End Malaria. She is co-Chair of the Global Pandemic Preparedness Monitoring Board (GPMB), and the Lancet pathfinder commission on climate change and health. She sits on the boards of the Clinton Health Access Initiative (CHAI) and the Partnership on Maternal, Newborn Child and Adolescent Health (PMNCH). She co-chaired the United Nations (UN) Secretary General’s Independent Accountability Panel for Every Woman, Every Child, Every Adolescent.

Katharina Lauer Vice President of Data and Partnerships, Airfinity

Dr Katharina Lauer is a health and biosecurity specialist and data strategist working at the intersection of biological risk, surveillance, and decision-making in high-stakes environments. She is Vice President of Data and Partnerships at Airfinity, where she leads the development of data-driven and AI-enabled platforms supporting infectious disease intelligence and global health decision-making. 

Her work focuses on how organisations turn complex, fragmented, and often uncertain data into actionable intelligence. This includes emerging approaches to surveillance, such as genomic data, digital, behavioural and environmental signals, and integrated data systems. 

She is particularly experienced in evaluating the reliability, limitations, and strategic use of data and modelling outputs in operational and commercially sensitive contexts, including the pharmaceutical and defence sectors, as well as the challenges of data sharing, trust, and coordination across systems. 

With a background in epidemic response in low- and middle-income countries, high-containment laboratory research, medical countermeasure development, large-scale data infrastructures, and commercial strategy, she brings a systems-level perspective that bridges science, technology, policy, and execution. She has conducted academic work at leading institutions including Harvard, Cambridge, and the University of Edinburgh. 

Tomas Cihlar Senior Vice President of Virology, Gilead Sciences | INTREPID Alliance
Regis Gervier Global Head, mRNA Center of Excellence, Sanofi
Vanina Laurent-Ledru Chief Public Health and Government Affairs Officer, Institut Mérieux & bioMérieux
David Reddy Director General, IFPMA
Top